N-benzyl-N'-(7-chloroquinolin-4-yl)ethane-1,2-diamine | 1145669-32-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-benzyl-N'-(7-chloroquinolin-4-yl)ethane-1,2-diamine
• 英文别名: N¹-benzyl-N²-(7-chloroquinolin-4-yl)ethane-1,2-diamine；N-benzyl-N'-(7-chloro-4-quinolyl)ethane-1,2-diamine
• CAS: 1145669-32-4
• 化学式: C₁₈H₁₈ClN₃
• 分子量: 311.814
• InChiKey: ONWNSKYYKRZUHC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  37
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-(2-氨基乙基)氨基-7-氯喹啉 、 苯甲醛 在 溶剂黄146 、 sodium tetrahydroborate 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 20.5h， 以66%的产率得到N-benzyl-N'-(7-chloroquinolin-4-yl)ethane-1,2-diamine
  参考文献：
  名称：

  4-Amino-7-chloroquinolines: Probing Ligand Efficiency Provides Botulinum Neurotoxin Serotype A Light Chain Inhibitors with Significant Antiprotozoal Activity

  摘要：

  Structurally simplified analogues of dual antimalarial and botulinum neurotoxin serotype A light chain (BoNT/A LC) inhibitor bis-aminoquinoline (1) were prepared. New compounds were designed to improve ligand efficiency while maintaining or exceeding the inhibitory potency of 1. Three of the new compounds are more active than 1 against both indications. Metabolically, the new inhibitors are relatively stable and nontoxic. 12, 14, and 15 are more potent BoNT/A LC inhibitors than 1. Additionally, 15 has excellent in vitro antimalarial efficacy, with IC90 values ranging from 4.45 to 12.11 nM against five Plasmodium falciparum (Pf) strains: W2, D6, C235, C2A, and C2B. The results indicate that the same level of inhibitory efficacy provided by 1 can be retained/exceeded with less structural complexity. 12, 14, and 15 provide new platforms for the development of more potent dual BoNT/A LC and P.f. inhibitors adhering to generally accepted chemical properties associated with the druggability of synthetic molecules.

  DOI：

  10.1021/jm4006077

文献信息

• Synthesis and in vitro antitubercular activity of a series of quinoline derivatives
  作者：Marcus V.N. de Souza、Karla C. Pais、Carlos R. Kaiser、Mônica A. Peralta、Marcelle de L. Ferreira、Maria C.S. Lourenço

  DOI：10.1016/j.bmc.2009.01.013

  日期：2009.2

  A series of 33 quinoline derivatives have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv using the Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Compounds 5e and 5f exhibited a significant activity at 6.25 and 3.12 μg/mL, respectively, when compared with first line

  合成了一系列33种喹啉衍生物，并使用Alamar Blue药敏试验评估了其对结核分枝杆菌H 37 Rv的体外抗菌活性，并以μg/ mL的最低抑菌浓度（MIC）表示了该活性。与一线药物（如乙胺丁醇）相比，化合物5e和5f分别在6.25和3.12μg/ mL处显示出显着活性，并且可能是开发新的抗多种药物耐药性先导化合物的良好起点。
• 4-Amino-7-chloroquinolines: Probing Ligand Efficiency Provides Botulinum Neurotoxin Serotype A Light Chain Inhibitors with Significant Antiprotozoal Activity
  作者：Igor M. Opsenica、Mikloš Tot、Laura Gomba、Jonathan E. Nuss、Richard J. Sciotti、Sina Bavari、James C. Burnett、Bogdan A. Šolaja

  DOI：10.1021/jm4006077

  日期：2013.7.25

  Structurally simplified analogues of dual antimalarial and botulinum neurotoxin serotype A light chain (BoNT/A LC) inhibitor bis-aminoquinoline (1) were prepared. New compounds were designed to improve ligand efficiency while maintaining or exceeding the inhibitory potency of 1. Three of the new compounds are more active than 1 against both indications. Metabolically, the new inhibitors are relatively stable and nontoxic. 12, 14, and 15 are more potent BoNT/A LC inhibitors than 1. Additionally, 15 has excellent in vitro antimalarial efficacy, with IC90 values ranging from 4.45 to 12.11 nM against five Plasmodium falciparum (Pf) strains: W2, D6, C235, C2A, and C2B. The results indicate that the same level of inhibitory efficacy provided by 1 can be retained/exceeded with less structural complexity. 12, 14, and 15 provide new platforms for the development of more potent dual BoNT/A LC and P.f. inhibitors adhering to generally accepted chemical properties associated with the druggability of synthetic molecules.